Novel oncogenic PTPN11 mutations in myelodysplastic syndrome in Korean patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|3|166-167

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.3, 2015-09, pp. : 166-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel oncogenic PTPN11 mutations in myelodysplastic syndrome in Korean patients

By  

Hematological Oncology (Electronic), Vol. 278-0232, Iss. 3, 2015-09 ,pp. : 166-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

By  

Current Cancer Drug Targets, Vol. 6, Iss. 6, 2006-09 ,pp. : 553-563

Bentham Science Publishers

Access to resources Recommend Favorite

Azacitidine beneficial in myelodysplastic syndrome

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Antiangiogenesis in Myelodysplastic Syndrome

By  

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-01 ,pp. : 1044-1052

Bentham Science Publishers

Access to resources Recommend Favorite

Venous Thromboembolism in Myelodysplastic Syndrome Patients Receiving Lenalidomide: Results from Postmarketing Surveillance and Data Mining Techniques

By Yang Xionghu  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 161-171

Adis International

Access to resources Recommend Favorite